-
Challenges in Predicting the Joint Clinical Assessment (JCA) Scope From a Stakeholder Perspective: A Case Study in Relapsed/Refractory Multiple Myeloma
Sep 9, 2025, 16:22 PM -
What Is the HTA Process for Medical Technologies in Scotland?
Sep 9, 2025, 16:22 PM -
Real-World Treatment Patterns of US Patients With Platinum-Resistant Ovarian Cancer
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Nonsquamous Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Türkiye
Sep 9, 2025, 16:22 PM -
Long-Term Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST): Investigating a Parametric Survival Model for Extrapolations
Sep 9, 2025, 16:22 PM -
Financing Sustainable Public Health: Design of a Herpes Zoster Prevention Bond to Fund Vaccination
Sep 9, 2025, 16:22 PM -
The Longevity Conundrum: Population Aging in the UK
Sep 9, 2025, 16:22 PM -
Review of Index Line Selection Methods in Hemato-Oncology Externally Controlled Trials: A Secondary Analysis of the Hermans et al Systematic Review
Sep 9, 2025, 16:22 PM -
Costs and Healthcare Resource Utilization Associated With Generalized Myasthenia Gravis: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Disease Progression Modeling for an Ultra-Rare Disease: Lysosomal Acid Lipase Deficiency (LAL-D)
Sep 9, 2025, 16:22 PM -
Exploring the Association Between Treatment Effects on Cure Rates and Overall Survival (OS) in Resected Stage II/III Melanoma: A Correlation Meta-Analysis (CMA) of Randomized Controlled Trials (RCTs)
Sep 9, 2025, 16:22 PM -
Anchors Away: Navigating Unanchored Indirect Comparisons With Multilevel Unanchored Meta-Regression (ML-UMR)
Sep 9, 2025, 16:22 PM -
Health Technology Assessment (HTA) Systems and Risk Identification Strategies: A Comparative Analysis Across Western European Countries, Canada, and Australia
Sep 9, 2025, 16:22 PM -
Impact of Prenatal Exposure to Antidepressants on Adverse Birth and Pregnancy Outcomes: A Propensity-Scored Matched Retrospective Cohort Study Using a Large Electronic Medical Record Database 2012-2021
Sep 9, 2025, 16:22 PM -
Addressing Payer Concerns: Opportunities for HEOR in Orphan Drug Development
Sep 9, 2025, 16:22 PM -
Modeling Early vs. Late Intervention Strategies: The Case of Dupilumab in Children With Severe Atopic Dermatitis
Sep 9, 2025, 16:22 PM -
Why TSD26 Matters: How Accurate Was Clinical Expert Opinion in Estimating Long-Term Outcomes?
Sep 9, 2025, 16:22 PM -
The Relevance of the Use of TENS Devices in the Therapy of Poststroke Dysphagia
Sep 9, 2025, 16:22 PM -
Reference Framework, Key Decision-Making Factors, and the Impact of Critical Parameters on Listing Recommendations for Nononcologic Drugs for Rare Diseases Issued by Canadian HTA Bodies
Sep 9, 2025, 16:22 PM -
Assessing the Sensitivity of EQ-5D-5L and AQoL-4D to Disease Severity in Von Willebrand Disease: Findings From UK Cohort of the PIVOT-vWD Study
Sep 9, 2025, 16:22 PM
